Melinta Therapeutics (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melinta Therapeutics" in English language version.

refsWebsite

Global rank English rank

1^st place

low place

low place

8,828^th place

2^nd place

low place

low place

49^th place

47^th place

bioworld.com

Osborne, Randy (20 June 2017). "Melinta's I.V., oral delafloxacin wins FDA nod in skin infections". BioWorld. Archived from the original on 3 August 2019. Retrieved 10 July 2017.

Cartwright, Heather (12 July 2011). "Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi". PharmaDeals Review. No. 7. doi:10.3833/pdr.v2011i7.1494 (inactive 1 November 2024). Archived from the original on 25 April 2012.{{cite news}}: CS1 maint: DOI inactive as of November 2024 (link)

Stearns, John (August 1, 2016). "Melinta Therapeutics takes aim at deadly drug-resistant bacteria". Hartford Business Journal.
Missakian, Natalie (April 23, 2020). "Antibiotics maker Melinta emerges from bankruptcy under new ownership". Hartford Business. Retrieved 23 November 2022.

Cartwright, Heather (12 July 2011). "Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi". PharmaDeals Review. No. 7. doi:10.3833/pdr.v2011i7.1494 (inactive 1 November 2024). Archived from the original on 25 April 2012.{{cite news}}: CS1 maint: DOI inactive as of November 2024 (link)

Cartwright, Heather (12 July 2011). "Rib-X Pharmaceuticals Signs Global Antibiotic Research Collaboration with Sanofi". PharmaDeals Review. No. 7. doi:10.3833/pdr.v2011i7.1494 (inactive 1 November 2024). Archived from the original on 25 April 2012.{{cite news}}: CS1 maint: DOI inactive as of November 2024 (link)
Osborne, Randy (20 June 2017). "Melinta's I.V., oral delafloxacin wins FDA nod in skin infections". BioWorld. Archived from the original on 3 August 2019. Retrieved 10 July 2017.